Zhouji Tongli Capital

Zhouji Tongli Capital

Zhouji Tongli Capital was established as the direct investment platform of Far East Horizon Limited, a Hong Kong-listed conglomerate historically backed by Sinochem Group. The parent's core business—providing equipment financing and operational leasing to small and medium-sized enterprises across China—generates a pipeline of potential equity targets that conventional funds rarely access. That embedded origination model is the firm's defining structural feature. The firm's mandate spans early-stage venture, growth equity, and PIPE transactions, with a disclosed concentration on advanced manufacturing, medical devices, and new energy services. Rather than raising blind-pool funds, Zhouji Tongli typically deploys capital in parallel with Far East Horizon's leasing and factoring divisions, taking minority or control positions in companies already known through years of credit history. This approach narrows due-diligence risk in a market where standalone private equity funds face intense competition for proprietary deals. Group-wide, Far East Horizon managed over RMB 350 billion in total assets at the end of 2024, with Zhouji Tongli representing a modest but strategically important equity sleeve alongside the group's dominant debt book. The firm maintains its primary operations in Shanghai and benefits from Far East Horizon's regulatory standing as a state-affiliated financial enterprise. In recent years, Zhouji Tongli has directed more attention toward medical consumables and renewable-energy equipment makers, aligning with Chinese industrial policy priorities. Structurally, the firm functions less like a conventional GP raising third-party commitments from institutional LPs and more like a captive corporate venture and growth equity unit deploying its parent's permanent capital. This balance-sheet permanence eliminates fundraising cycles and allows Zhouji Tongli to hold positions through down-cycles without redemption pressure—a genuine differentiator in China's often liquidity-constrained private equity market.